Cargando...
Genetically Modified T-Cell Therapy for Osteosarcoma: Into the Roaring 2020s
T-cell immunotherapy may offer an approach to improve outcomes for patients with osteosarcoma who fail current therapies. In addition, it has the potential to reduce treatment-related complications for all patients. Generating tumor-specific T cells with conventional antigen-presenting cells ex vivo...
Gardado en:
| Publicado en: | Adv Exp Med Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7385999/ https://ncbi.nlm.nih.gov/pubmed/32483735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-3-030-43032-0_10 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|